Geode Capital Management’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$127K Sell
109,083
-2,425
-2% -$2.81K ﹤0.01% 4007
2025
Q1
$103K Buy
111,508
+3,175
+3% +$2.94K ﹤0.01% 4024
2024
Q4
$93.2K Hold
108,333
﹤0.01% 4113
2024
Q3
$180K Buy
108,333
+12,856
+13% +$21.3K ﹤0.01% 3936
2024
Q2
$154K Buy
95,477
+10,689
+13% +$17.2K ﹤0.01% 4004
2024
Q1
$194K Hold
84,788
﹤0.01% 3949
2023
Q4
$191K Hold
84,788
﹤0.01% 3958
2023
Q3
$256K Buy
84,788
+3,007
+4% +$9.08K ﹤0.01% 3880
2023
Q2
$337K Hold
81,781
﹤0.01% 3802
2023
Q1
$307K Buy
81,781
+14,835
+22% +$55.6K ﹤0.01% 3852
2022
Q4
$374K Buy
+66,946
New +$374K ﹤0.01% 3813
2022
Q3
Sell
-73,283
Closed -$729K 5041
2022
Q2
$729K Sell
73,283
-59,278
-45% -$590K ﹤0.01% 3562
2022
Q1
$2.52M Buy
132,561
+2,211
+2% +$42K ﹤0.01% 3145
2021
Q4
$2.32M Sell
130,350
-9,659
-7% -$172K ﹤0.01% 3298
2021
Q3
$5.19M Buy
140,009
+16,409
+13% +$608K ﹤0.01% 2893
2021
Q2
$7.35M Buy
123,600
+12,478
+11% +$742K ﹤0.01% 2669
2021
Q1
$7.45M Buy
111,122
+35,043
+46% +$2.35M ﹤0.01% 2561
2020
Q4
$4.6M Buy
76,079
+6,099
+9% +$369K ﹤0.01% 2647
2020
Q3
$5.53M Sell
69,980
-1,416
-2% -$112K ﹤0.01% 2332
2020
Q2
$4.46M Buy
71,396
+4,531
+7% +$283K ﹤0.01% 2400
2020
Q1
$3.54M Buy
66,865
+6,596
+11% +$350K ﹤0.01% 2344
2019
Q4
$7.29M Buy
60,269
+6,171
+11% +$747K ﹤0.01% 2227
2019
Q3
$9.82M Buy
54,098
+693
+1% +$126K ﹤0.01% 1944
2019
Q2
$6.94M Buy
53,405
+4,730
+10% +$615K ﹤0.01% 2181
2019
Q1
$11.9M Buy
48,675
+4,551
+10% +$1.11M ﹤0.01% 1777
2018
Q4
$8.41M Buy
44,124
+3,661
+9% +$697K ﹤0.01% 1889
2018
Q3
$13.3M Buy
40,463
+4,316
+12% +$1.42M ﹤0.01% 1714
2018
Q2
$11.3M Buy
36,147
+3,455
+11% +$1.08M ﹤0.01% 1787
2018
Q1
$7.96M Buy
32,692
+556
+2% +$135K ﹤0.01% 1926
2017
Q4
$9.7M Buy
32,136
+5,289
+20% +$1.6M ﹤0.01% 1765
2017
Q3
$7.1M Buy
26,847
+715
+3% +$189K ﹤0.01% 1982
2017
Q2
$6.89M Buy
26,132
+540
+2% +$142K ﹤0.01% 1920
2017
Q1
$9.21M Buy
25,592
+2,353
+10% +$847K ﹤0.01% 1674
2016
Q4
$6.7M Buy
23,239
+2,722
+13% +$785K ﹤0.01% 1862
2016
Q3
$6.99M Buy
20,517
+255
+1% +$86.8K ﹤0.01% 1735
2016
Q2
$8.61M Buy
20,262
+835
+4% +$355K ﹤0.01% 1547
2016
Q1
$6.22K Buy
19,427
+2,543
+15% +$814 ﹤0.01% 1730
2015
Q4
$8.75M Buy
16,884
+1,347
+9% +$698K 0.01% 1466
2015
Q3
$4.55M Buy
15,537
+792
+5% +$232K ﹤0.01% 1897
2015
Q2
$5.79M Buy
14,745
+1,363
+10% +$536K ﹤0.01% 1797
2015
Q1
$4.05M Buy
13,382
+315
+2% +$95.3K ﹤0.01% 1986
2014
Q4
$2.91M Buy
13,067
+1,042
+9% +$232K ﹤0.01% 2177
2014
Q3
$2.79M Buy
12,025
+2,113
+21% +$490K ﹤0.01% 2157
2014
Q2
$2.19M Buy
9,912
+285
+3% +$63K ﹤0.01% 2316
2014
Q1
$3.04M Buy
9,627
+119
+1% +$37.5K ﹤0.01% 2088
2013
Q4
$2.48M Buy
9,508
+6,044
+174% +$1.57M ﹤0.01% 2161
2013
Q3
$507K Buy
3,464
+298
+9% +$43.6K ﹤0.01% 2941
2013
Q2
$480K Buy
+3,166
New +$480K ﹤0.01% 2900